IA
SABS icon

IFP Advisors’s SAB Biotherapeutics SABS Stock Holding History

IFP Advisors’s Portfolio SABS Stock Details SABS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$151K Buy
+38,699
New +$144K ﹤0.01% 1704

Other funds holding SABS

SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
FPB
First PREMIER Bank Sioux Falls, South Dakota $619M AUM 20.21% 1-Year Est. Return

IFP Advisors's SABS Position: Q2 2026 in Review

IFP Advisors opened a new position in SAB Biotherapeutics (SABS) in Q2 2026: 38,699 shares worth $151K. The stake represents ﹤0.01% of the portfolio and ranks #1704 among its holdings.

3 funds tracked by Wall St. Rank hold SABS as of Q2 2026.

  • IFP Advisors held 38,699 shares of SAB Biotherapeutics worth $151K as of Q2 2026.
  • SAB Biotherapeutics was a new IFP Advisors position in Q2 2026.
  • SAB Biotherapeutics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #1704 holding.
  • 3 funds tracked by Wall St. Rank held SAB Biotherapeutics as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.